JCRB0189 KYSE50

Cell information

Important Notice(s)

KYSEシリーズ細胞株の民間企業への分譲について

On the MTA of KYSE series cell lines with Kyoto University (for profit organizations)

KYSEシリーズ細胞株の使用について

Announcement of unavailability of KYSE series cell lines to oversea users outside of Japan

Cell type:general cells (Charges for cells)

JCRB No.   JCRB0189 Cell Name   KYSE50
profile   Stop providing for the issue of quality control. (Please contact us for more information) Poorly differentiated human squamous cell carcinoma from esophageal cancer. Alias   
animal   human strain   
genus   Homo species   sapiens
sex   M age   58
identity   available tissue   esophagus
case history   esophageal cancer, lower intrathoracic esophagus, poorly differentiated squamous cell carcinoma. metastasis   No
metastorgn    genetics   Mode of chromosome number = 105-120. DNA fingerprint indicated the cell line was unique.
lifespan   infinite crisispdl   
morphology   epithelial-like charact   Cell line was established from inplanted tumor of nude mice (only initial passage).
classify    originator   Shimada,Y. et.al.
register   Shimada,Y. regulation   Cite reference {5368}. Company users require MTA from the originator. See additional information.
comment   Distribution restricted to Japan(domestic use only). dyear   2001
medium   Dulbecco's modified Eagle's medium with 2% fetal calf serum. pasmethod   5% CO2, 37 C.
pascellno    race   Japanese
co2conc   5 % tohroku   registered
preporgn   esophagus vrsummary   tested
vrsdetect   CMV(-), EBV(-), HHV6(-), HHV7(-), BKV(-), JCV(-), ADV(-), parvoB19(-), HBV(-), HTLV1(-), HTLV2(-), HIV1(-), HIV2(-), HPV18(-) [-/negative, +/positive, nt/not tested] tissueform   


References
Pubmed id:9033652 Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines.
Tanaka H,Shimada Y,Imamura M,Shibagaki I,Ishizaki K
Int J Cancer. 1997 Feb 7;70(4):437-42
Pubmed id:8575860 Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors.
Tanaka H,Shibagaki I,Shimada Y,Wagata T,Imamura M,Ishizaki K
Int J Cancer. 1996 Jan 26;65(3):372-6
Pubmed id:1728357 Characterization of 21 newly established esophageal cancer cell lines.
Shimada Y,Imamura M,Wagata T,Yamaguchi N,Tobe T
Cancer. 1992 Jan 15;69(2):277-84
Images



LOT Information

Cell No.   JCRB0189 Cell Name   
LOT No.   02182005 LOTSPEC   distribution
MEDIUM   Dulbecco's modified Eagle's medium with 2% fetal bovine serum (FBS lot; GIBCO 3762782S) GROWTEMP   37 C
PASCELLNO   1.5 - 2.0 x 10^5 cells/ml PASMETHOD   200 units/ml trypsin and 0.01% EDTA
GROWTHRATE   ca. 2-3 days FREEZCONC   1.4 x 10^6
VIABLFREEZ   87.4 ANTIBIOTIC   free
PASSAGE   P6 at bank PDL   
MYCO   - BACT   -
PROTOZOA    ISOZYME   Confirmed as human by NP, G6PD (type B), MD.
CHRMODE    CHRDISTRB   
SURFACEAG    DNA Profile (STR)   
ANCHORDEPD   Yes EXOGENE   
FMEDIUM   10% DMSO, 20% FBS - DMEM CO2   5%
SCFREQ    RFLP   
FROMLOT   


CLOSE